查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2067670

免疫檢測市場規模、佔有率和趨勢分析報告：按產品、技術、應用、最終用途、檢體類型、地區和細分市場預測（2026-2033 年）

Immunoassay Market Size, Share & Trends Analysis Report By Product, By Technology (Radioimmunoassay, Enzyme Immunoassays, Rapid Test), By Application (Oncology, Cardiology), By End-use, By Specimen, By Region, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 190 Pages | 商品交期: 2-10個工作天內

價格

免疫檢測市場概覽

全球免疫檢測市場預計到 2025 年價值 280.5 億美元，預計到 2033 年將達到 402.5 億美元。

受精準醫療需求不斷成長的推動，預計該領域在2026年至2033年間將以4.63%的複合年成長率成長。免疫檢測在提供個人化治療方面發揮著至關重要的作用，它能夠識別預測特定治療方法療效的生物標記。

癌症、心血管疾病和自體免疫疾病的日益流行，使得標靶治療的需求不斷成長，而免疫檢測正幫助確定每位患者最有效的治療方法。這種方法可以最大限度地減少副作用，提高治療效果，並改善患者的預後。從統一的治療方案轉向個人化醫療的轉變，是推動市場擴張的主要動力。此外，製藥公司正擴大將免疫檢測納入其藥物開發平臺，以提高新療法的成功率，這進一步加速了市場成長。

目錄

第1章：調查方法和範圍

第2章執行摘要

第3章：免疫檢測市場：變數、趨勢與範圍

  • 市場概況及未來展望
  • 市場規模/成長前景
  • 市場動態
  • 免疫檢測市場分析工具

第4章免疫檢測市場：依產品分類的估算與趨勢分析

  • 免疫檢測市場：基於產品的波動分析
  • 免疫檢測市場估算與預測：依產品分類，2025 年及 2033 年
  • 檢測方法、試劑盒、試劑
    • ELISA試劑和試劑盒
    • 快速檢測試劑和試劑盒
    • ELISPOT試劑與試劑盒
    • 西方墨點法試劑和試劑盒
    • 其他試劑和試劑盒
  • 分析儀器/測量儀器
    • 開放式系統
    • 封閉式系統
  • 軟體和服務

第5章免疫檢測市場：按應用、估算和趨勢分析

  • 免疫檢測市場：基於應用的波動分析
  • 免疫檢測市場，按應用領域分類的估算和預測，2025 年和 2033 年
  • 治療監測
  • 腫瘤學
  • 循環系統
  • 內分泌學
  • 傳染病檢查
  • 自體免疫疾病
  • 其他

第6章免疫檢測市場：依技術分類的估算與趨勢分析

  • 免疫檢測市場：基於技術的波動分析
  • 免疫檢測市場估算與預測：依技術分類，2025 年及 2033 年
  • 免疫測量（RIA）
  • 酵素免疫分析法（EIA）
    • 化學冷光免疫檢測（CLIA）
    • 螢光免疫分析（FIA）
  • 快速檢測
  • 其他

第7章：免疫檢測市場：依樣本類型分類的檢體與趨勢分析

  • 免疫檢測市場：按檢體類型分類的差異分析
  • 免疫檢測市場估算與預測：按檢體類型分類，2025 年和 2033 年
  • 血
  • 唾液
  • 尿
  • 其他

第8章免疫檢測市場：依最終用途分類的估算與趨勢分析

  • 免疫檢測市場：依最終用途分類的波動分析
  • 免疫檢測市場估算與預測：依最終用途分類，2025 年及 2033 年
  • 醫院
  • 血庫
  • 臨床實驗室
  • 製藥和生物技術公司
  • 學術研究機構
  • 其他

第9章免疫檢測市場：區域、估算與趨勢分析

  • 2025年及2033年免疫檢測市場的區域市場佔有率
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第10章 競爭格局

  • 主要市場參與企業近期趨勢及影響分析
  • 公司分類
  • 企業熱力圖分析
  • 公司簡介
  • Abbott
  • Siemens Healthineers AG
  • Danaher Corporation（Beckman Coulter）
  • bioMerieux SA
  • Quidel Corporation
  • Sysmex Corporation
  • Ortho Clinical Diagnostics
  • Bio-Rad Laboratories, Inc.
  • F. Hoffmann-La Roche AG
  • Becton, Dickinson and Company
  • Thermo Fisher Scientific, Inc.
Product Code: GVR-3-68038-066-8

Immunoassay Market Summary

The global immunoassay market size was estimated at USD 28.05 billion in 2025 and is projected to reach USD 40.25 billion by 2033, growing at a CAGR of 4.63% from 2026 to 2033, driven by increasing demand for precision medicine. Immunoassays play a crucial role in tailoring treatments to individual patients by identifying biomarkers that predict responses to specific therapies.

The rising prevalence of cancer, cardiovascular diseases, and autoimmune disorders has driven the need for targeted therapies, where immunoassays help determine the most effective treatment for patients. This approach minimizes adverse effects and enhances treatment efficacy, improving patient outcomes. The shift from a one-size-fits-all treatment approach to personalized medicine is a primary driver of market expansion. Furthermore, pharmaceutical companies are increasingly integrating immunoassays into drug development pipelines to improve the success rate of novel therapeutics, further accelerating market growth.

Global Immunoassay Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends across sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global immunoassay market report based on product, specimen, technology, application, end-use, and region:

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Reagents & Kits
    • ELISA Reagents & Kits
    • Rapid Tests Reagents & Kits
    • ELISPOT Reagents & Kits
    • Western Blot Reagents & Kits
    • Other Reagents & Kits
  • Analyzers/Instruments
    • Open-Ended Systems
    • Closed-Ended Systems
  • Software & Services
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Therapeutic Drug Monitoring
  • Oncology
  • Cardiology
  • Endocrinology
  • Infectious Disease Testing
  • Autoimmune Diseases
  • Others
  • Technology Outlook (Revenue, USD Million, 2021 - 2033)
  • Radioimmunoassay (RIA)
  • Enzyme Immunoassays (EIA)
    • Chemiluminescence Immunoassays (CLIA)
    • Fluorescence Immunoassays (FIA)
  • Rapid Test
  • Others
  • Specimen Outlook (Revenue, USD Million, 2021 - 2033)
  • Blood
  • Saliva
  • Urine
  • Others
  • End-use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals
  • Blood Banks
  • Clinical Laboratories
  • Pharmaceutical and Biotech Companies
  • Academic Research Centers
  • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Immunoassay Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
      • 3.3.1.1. Rising incidence of chronic and infectious diseases
      • 3.3.1.2. Increasing demand for point-of-care diagnostics
      • 3.3.1.3. Growing demand for portable and automated immunoassays
    • 3.3.2. Market Restraints Analysis
      • 3.3.2.1. Lower detection limit
      • 3.3.2.2. Limitations associated with immunoassay techniques
  • 3.4. Immunoassay Market Analysis Tools
    • 3.4.1. Porter's Five Forces Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Immunoassay Market: Product Estimates & Trend Analysis

  • 4.1. Immunoassay Market: Product Movement Analysis
  • 4.2. Immunoassay Market Estimates and Forecasts, by Product (USD Million), 2025 & 2033
  • 4.3. Assays, Kits, and Reagents
    • 4.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.3.2. ELISA Reagents & Kits
      • 4.3.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.3.3. Rapid Tests Reagents & Kits
      • 4.3.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.3.4. ELISPOT Reagents & Kits
      • 4.3.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.3.5. Western Blot Reagents & Kits
      • 4.3.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.3.6. Other Reagents & Kits
      • 4.3.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4. Analyzers/Instruments
    • 4.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.2. Open Ended Systems
      • 4.4.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.3. Closed Ended Systems
      • 4.4.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5. Software and Services
    • 4.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Immunoassay Market: Application Estimates & Trend Analysis

  • 5.1. Immunoassay Market: Application Movement Analysis
  • 5.2. Immunoassay Market Estimates and Forecasts, by Application (USD Million), 2025 & 2033
  • 5.3. Therapeutic Drug Monitoring
    • 5.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.4. Oncology
    • 5.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5. Cardiology
    • 5.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6. Endocrinology
    • 5.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.7. Infectious Disease Testing
    • 5.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.8. Autoimmune Diseases
    • 5.8.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.9. Others
    • 5.9.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Immunoassay Market: Technology Estimates & Trend Analysis

  • 6.1. Immunoassay Market: Technology Movement Analysis
  • 6.2. Immunoassay Market Estimates and Forecasts, by Technology (USD Million), 2025 & 2033
  • 6.3. Radioimmunoassay (RIA)
    • 6.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.4. Enzyme Immunoassays (EIA)
    • 6.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.2. Chemiluminescence Immunoassays (CLIA)
      • 6.4.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.3. Fluorescence Immunoassays (FIA)
      • 6.4.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Rapid Test
    • 6.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Others
    • 6.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Immunoassay Market: Specimen Estimates & Trend Analysis

  • 7.1. Immunoassay Market: Specimen Movement Analysis
  • 7.2. Immunoassay Market Estimates and Forecasts, by Specimen (USD Million), 2025 & 2033
  • 7.3. Blood
    • 7.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.4. Saliva
    • 7.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5. Urine
    • 7.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6. Others
    • 7.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Immunoassay Market: End Use Estimates & Trend Analysis

  • 8.1. Immunoassay Market: End-use Movement Analysis
  • 8.2. Immunoassay Market Estimates and Forecasts, by End Use (USD Million), 2025 & 2033
  • 8.3. Hospitals
    • 8.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4. Blood Banks
    • 8.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5. Clinical Laboratories
    • 8.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.6. Pharmaceutical and Biotech Companies
    • 8.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.7. Academic Research Centers
    • 8.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.8. Others
    • 8.8.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 9. Immunoassay Market: Regional Estimates & Trend Analysis

  • 9.1. Immunoassay Market Share, By Region, 2025 & 2033, USD Million
  • 9.2. North America
    • 9.2.1. North America Immunoassay Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.2.2. U.S.
      • 9.2.2.1. Key Country Dynamics
      • 9.2.2.2. Target Disease Prevalence
      • 9.2.2.3. Competitive Scenario
      • 9.2.2.4. Regulatory Framework
      • 9.2.2.5. Reimbursement Scenario
      • 9.2.2.6. U.S. Immunoassay Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.2.3. Canada
      • 9.2.3.1. Key Country Dynamics
      • 9.2.3.2. Target Disease Prevalence
      • 9.2.3.3. Competitive Scenario
      • 9.2.3.4. Regulatory Framework
      • 9.2.3.5. Reimbursement Scenario
      • 9.2.3.6. Canada Immunoassay Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.2.4. Mexico
      • 9.2.4.1. Key Country Dynamics
      • 9.2.4.2. Target Disease Prevalence
      • 9.2.4.3. Competitive Scenario
      • 9.2.4.4. Regulatory Framework
      • 9.2.4.5. Reimbursement Scenario
      • 9.2.4.6. Mexico Immunoassay Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.3. Europe
    • 9.3.1. Europe Immunoassay Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.3.2. UK
      • 9.3.2.1. Key Country Dynamics
      • 9.3.2.2. Target Disease Prevalence
      • 9.3.2.3. Competitive Scenario
      • 9.3.2.4. Regulatory Framework
      • 9.3.2.5. Reimbursement Scenario
      • 9.3.2.6. UK Immunoassay Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.3.3. Germany
      • 9.3.3.1. Key Country Dynamics
      • 9.3.3.2. Target Disease Prevalence
      • 9.3.3.3. Competitive Scenario
      • 9.3.3.4. Regulatory Framework
      • 9.3.3.5. Reimbursement Scenario
      • 9.3.3.6. Germany Immunoassay Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.3.4. France
      • 9.3.4.1. Key Country Dynamics
      • 9.3.4.2. Target Disease Prevalence
      • 9.3.4.3. Competitive Scenario
      • 9.3.4.4. Regulatory Framework
      • 9.3.4.5. Reimbursement Scenario
      • 9.3.4.6. France Immunoassay Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.3.5. Italy
      • 9.3.5.1. Key Country Dynamics
      • 9.3.5.2. Target Disease Prevalence
      • 9.3.5.3. Competitive Scenario
      • 9.3.5.4. Regulatory Framework
      • 9.3.5.5. Reimbursement Scenario
      • 9.3.5.6. Italy Immunoassay Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.3.6. Spain
      • 9.3.6.1. Key Country Dynamics
      • 9.3.6.2. Target Disease Prevalence
      • 9.3.6.3. Competitive Scenario
      • 9.3.6.4. Regulatory Framework
      • 9.3.6.5. Reimbursement Scenario
      • 9.3.6.6. Spain Immunoassay Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.3.7. Denmark
      • 9.3.7.1. Key Country Dynamics
      • 9.3.7.2. Target Disease Prevalence
      • 9.3.7.3. Competitive Scenario
      • 9.3.7.4. Regulatory Framework
      • 9.3.7.5. Reimbursement Scenario
      • 9.3.7.6. Denmark Immunoassay Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.3.8. Sweden
      • 9.3.8.1. Key Country Dynamics
      • 9.3.8.2. Target Disease Prevalence
      • 9.3.8.3. Competitive Scenario
      • 9.3.8.4. Regulatory Framework
      • 9.3.8.5. Reimbursement Scenario
      • 9.3.8.6. Sweden Immunoassay Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.3.9. Norway
      • 9.3.9.1. Key Country Dynamics
      • 9.3.9.2. Target Disease Prevalence
      • 9.3.9.3. Competitive Scenario
      • 9.3.9.4. Regulatory Framework
      • 9.3.9.5. Reimbursement Scenario
      • 9.3.9.6. Norway Immunoassay Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.4. Asia Pacific
    • 9.4.1. Asia Pacific Immunoassay Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.4.2. Japan
      • 9.4.2.1. Key Country Dynamics
      • 9.4.2.2. Target Disease Prevalence
      • 9.4.2.3. Competitive Scenario
      • 9.4.2.4. Regulatory Framework
      • 9.4.2.5. Reimbursement Scenario
      • 9.4.2.6. Japan Immunoassay Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.4.3. China
      • 9.4.3.1. Key Country Dynamics
      • 9.4.3.2. Target Disease Prevalence
      • 9.4.3.3. Competitive Scenario
      • 9.4.3.4. Regulatory Framework
      • 9.4.3.5. Reimbursement Scenario
      • 9.4.3.6. China Immunoassay Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.4.4. India
      • 9.4.4.1. Key Country Dynamics
      • 9.4.4.2. Target Disease Prevalence
      • 9.4.4.3. Competitive Scenario
      • 9.4.4.4. Regulatory Framework
      • 9.4.4.5. Reimbursement Scenario
      • 9.4.4.6. India Immunoassay Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.4.5. Australia
      • 9.4.5.1. Key Country Dynamics
      • 9.4.5.2. Target Disease Prevalence
      • 9.4.5.3. Competitive Scenario
      • 9.4.5.4. Regulatory Framework
      • 9.4.5.5. Reimbursement Scenario
      • 9.4.5.6. Australia Immunoassay Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.4.6. South Korea
      • 9.4.6.1. Key Country Dynamics
      • 9.4.6.2. Target Disease Prevalence
      • 9.4.6.3. Competitive Scenario
      • 9.4.6.4. Regulatory Framework
      • 9.4.6.5. Reimbursement Scenario
      • 9.4.6.6. South Korea Immunoassay Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.4.7. Thailand
      • 9.4.7.1. Key Country Dynamics
      • 9.4.7.2. Target Disease Prevalence
      • 9.4.7.3. Competitive Scenario
      • 9.4.7.4. Regulatory Framework
      • 9.4.7.5. Reimbursement Scenario
      • 9.4.7.6. Thailand Immunoassay Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.5. Latin America
    • 9.5.1. Latin America Immunoassay Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.5.2. Brazil
      • 9.5.2.1. Key Country Dynamics
      • 9.5.2.2. Target Disease Prevalence
      • 9.5.2.3. Competitive Scenario
      • 9.5.2.4. Regulatory Framework
      • 9.5.2.5. Reimbursement Scenario
      • 9.5.2.6. Brazil Immunoassay Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.5.3. Argentina
      • 9.5.3.1. Key Country Dynamics
      • 9.5.3.2. Target Disease Prevalence
      • 9.5.3.3. Competitive Scenario
      • 9.5.3.4. Regulatory Framework
      • 9.5.3.5. Reimbursement Scenario
      • 9.5.3.6. Argentina Immunoassay Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.6. Middle East and Africa
    • 9.6.1. Middle East and Africa Immunoassay Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.6.2. South Africa
      • 9.6.2.1. Key Country Dynamics
      • 9.6.2.2. Target Disease Prevalence
      • 9.6.2.3. Competitive Scenario
      • 9.6.2.4. Regulatory Framework
      • 9.6.2.5. Reimbursement Scenario
      • 9.6.2.6. South Africa Immunoassay Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.6.3. Saudi Arabia
      • 9.6.3.1. Key Country Dynamics
      • 9.6.3.2. Target Disease Prevalence
      • 9.6.3.3. Competitive Scenario
      • 9.6.3.4. Regulatory Framework
      • 9.6.3.5. Reimbursement Scenario
      • 9.6.3.6. Saudi Arabia Immunoassay Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.6.4. UAE
      • 9.6.4.1. Key Country Dynamics
      • 9.6.4.2. Target Disease Prevalence
      • 9.6.4.3. Competitive Scenario
      • 9.6.4.4. Regulatory Framework
      • 9.6.4.5. Reimbursement Scenario
      • 9.6.4.6. UAE Immunoassay Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.6.5. Kuwait
      • 9.6.5.1. Key Country Dynamics
      • 9.6.5.2. Target Disease Prevalence
      • 9.6.5.3. Competitive Scenario
      • 9.6.5.4. Regulatory Framework
      • 9.6.5.5. Reimbursement Scenario
      • 9.6.5.6. Kuwait Immunoassay Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 10. Competitive Landscape

  • 10.1. Recent Developments & Impact Analysis by Key Market Participants
  • 10.2. Company Categorization
  • 10.3. Company Heat Map Analysis
  • 10.4. Company Profiles
  • 10.5. Abbott
    • 10.5.1. Participant's Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Developments/ Strategic Initiatives
  • 10.6. Siemens Healthineers AG
    • 10.6.1. Participant's Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Developments/ Strategic Initiatives
  • 10.7. Danaher Corporation (Beckman Coulter)
    • 10.7.1. Participant's Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Developments/ Strategic Initiatives
  • 10.8. bioMerieux SA
    • 10.8.1. Participant's Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Developments/ Strategic Initiatives
  • 10.9. Quidel Corporation
    • 10.9.1. Participant's Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Developments/ Strategic Initiatives
  • 10.10. Sysmex Corporation
    • 10.10.1. Participant's Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Developments/ Strategic Initiatives
  • 10.11. Ortho Clinical Diagnostics
    • 10.11.1. Participant's Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Developments/ Strategic Initiatives
  • 10.12. Bio-Rad Laboratories, Inc.
    • 10.12.1. Participant's Overview
    • 10.12.2. Financial Performance
    • 10.12.3. Product Benchmarking
    • 10.12.4. Recent Developments/ Strategic Initiatives
  • 10.13. F. Hoffmann-La Roche AG
    • 10.13.1. Participant's Overview
    • 10.13.2. Financial Performance
    • 10.13.3. Product Benchmarking
    • 10.13.4. Recent Developments/ Strategic Initiatives
  • 10.14. Becton, Dickinson, and Company
    • 10.14.1. Participant's Overview
    • 10.14.2. Financial Performance
    • 10.14.3. Product Benchmarking
    • 10.14.4. Recent Developments/ Strategic Initiatives
  • 10.15. Thermo Fisher Scientific, Inc.
    • 10.15.1. Participant's Overview
    • 10.15.2. Financial Performance
    • 10.15.3. Product Benchmarking
    • 10.15.4. Recent Developments/ Strategic Initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 Global immunoassay market, by region, 2021 - 2033 (USD Million)
  • Table 3 Global immunoassay market, by product, 2021 - 2033 (USD Million)
  • Table 4 Global immunoassay market, by technology, 2021 - 2033 (USD Million)
  • Table 5 Global immunoassay market, by application, 2021 - 2033 (USD Million)
  • Table 6 Global immunoassay market, by specimen, 2021 - 2033 (USD Million)
  • Table 7 Global immunoassay market, by end use, 2021 - 2033 (USD Million)
  • Table 8 North America immunoassay market, by country, 2021 - 2033 (USD Million)
  • Table 9 North America immunoassay market, by product, 2021 - 2033 (USD Million)
  • Table 10 North America immunoassay market, by application, 2021 - 2033 (USD Million)
  • Table 11 North America immunoassay market, by technology, 2021 - 2033 (USD Million)
  • Table 12 North America immunoassay market, by specimen, 2021 - 2033 (USD Million)
  • Table 13 North America immunoassay market, by end use, 2021 - 2033 (USD Million)
  • Table 14 U.S. immunoassay market, by product, 2021 - 2033 (USD Million)
  • Table 15 U.S. immunoassay market, by application, 2021 - 2033 (USD Million)
  • Table 16 U.S. immunoassay market, by technology, 2021 - 2033 (USD Million)
  • Table 17 U.S. immunoassay market, by specimen, 2021 - 2033 (USD Million)
  • Table 18 U.S. immunoassay market, by end use, 2021 - 2033 (USD Million)
  • Table 19 Canada immunoassay market, by product, 2021 - 2033 (USD Million)
  • Table 20 Canada immunoassay market, by application, 2021 - 2033 (USD Million)
  • Table 21 Canada immunoassay market, by technology, 2021 - 2033 (USD Million)
  • Table 22 Canada immunoassay market, by specimen, 2021 - 2033 (USD Million)
  • Table 23 Canada immunoassay market, by end use, 2021 - 2033 (USD Million)
  • Table 24 Mexico immunoassay market, by product, 2021 - 2033 (USD Million)
  • Table 25 Mexico immunoassay market, by application, 2021 - 2033 (USD Million)
  • Table 26 Mexico immunoassay market, by technology, 2021 - 2033 (USD Million)
  • Table 27 Mexico immunoassay market, by specimen, 2021 - 2033 (USD Million)
  • Table 28 Mexico immunoassay market, by end use, 2021 - 2033 (USD Million)
  • Table 29 Europe immunoassay market, by country, 2021 - 2033 (USD Million)
  • Table 30 Europe immunoassay market, by product, 2021 - 2033 (USD Million)
  • Table 31 Europe immunoassay market, by application, 2021 - 2033 (USD Million)
  • Table 32 Europe immunoassay market, by technology, 2021 - 2033 (USD Million)
  • Table 33 Europe immunoassay market, by specimen, 2021 - 2033 (USD Million)
  • Table 34 Europe immunoassay market, by end use, 2021 - 2033 (USD Million)
  • Table 35 UK immunoassay market, by product, 2021 - 2033 (USD Million)
  • Table 36 UK immunoassay market, by application, 2021 - 2033 (USD Million)
  • Table 37 UK immunoassay market, by technology, 2021 - 2033 (USD Million)
  • Table 38 UK immunoassay market, by specimen, 2021 - 2033 (USD Million)
  • Table 39 UK immunoassay market, by end use, 2021 - 2033 (USD Million)
  • Table 40 Germany immunoassay market, by product, 2021 - 2033 (USD Million)
  • Table 41 Germany immunoassay market, by application, 2021 - 2033 (USD Million)
  • Table 42 Germany immunoassay market, by technology, 2021 - 2033 (USD Million)
  • Table 43 Germany immunoassay market, by specimen, 2021 - 2033 (USD Million)
  • Table 44 Germany immunoassay market, by end use, 2021 - 2033 (USD Million)
  • Table 45 France immunoassay market, by product, 2021 - 2033 (USD Million)
  • Table 46 France immunoassay market, by application, 2021 - 2033 (USD Million)
  • Table 47 France immunoassay market, by technology, 2021 - 2033 (USD Million)
  • Table 48 France immunoassay market, by specimen, 2021 - 2033 (USD Million)
  • Table 49 France immunoassay market, by end use, 2021 - 2033 (USD Million)
  • Table 50 Italy immunoassay market, by product, 2021 - 2033 (USD Million)
  • Table 51 Italy immunoassay market, by application, 2021 - 2033 (USD Million)
  • Table 52 Italy immunoassay market, by technology, 2021 - 2033 (USD Million)
  • Table 53 Italy immunoassay market, by specimen, 2021 - 2033 (USD Million)
  • Table 54 Italy immunoassay market, by end use, 2021 - 2033 (USD Million)
  • Table 55 Spain immunoassay market, by product, 2021 - 2033 (USD Million)
  • Table 56 Spain immunoassay market, by application, 2021 - 2033 (USD Million)
  • Table 57 Spain immunoassay market, by technology, 2021 - 2033 (USD Million)
  • Table 58 Spain immunoassay market, by specimen, 2021 - 2033 (USD Million)
  • Table 59 Spain immunoassay market, by end use, 2021 - 2033 (USD Million)
  • Table 60 Denmark immunoassay market, by product, 2021 - 2033 (USD Million)
  • Table 61 Denmark immunoassay market, by application, 2021 - 2033 (USD Million)
  • Table 62 Denmark immunoassay market, by technology, 2021 - 2033 (USD Million)
  • Table 63 Denmark immunoassay market, by specimen, 2021 - 2033 (USD Million)
  • Table 64 Denmark immunoassay market, by end use, 2021 - 2033 (USD Million)
  • Table 65 Sweden immunoassay market, by product, 2021 - 2033 (USD Million)
  • Table 66 Sweden immunoassay market, by application, 2021 - 2033 (USD Million)
  • Table 67 Sweden immunoassay market, by technology, 2021 - 2033 (USD Million)
  • Table 68 Sweden immunoassay market, by specimen, 2021 - 2033 (USD Million)
  • Table 69 Sweden immunoassay market, by end use, 2021 - 2033 (USD Million)
  • Table 70 Norway immunoassay market, by product, 2021 - 2033 (USD Million)
  • Table 71 Norway immunoassay market, by application, 2021 - 2033 (USD Million)
  • Table 72 Norway immunoassay market, by technology, 2021 - 2033 (USD Million)
  • Table 73 Norway immunoassay market, by specimen, 2021 - 2033 (USD Million)
  • Table 74 Norway immunoassay market, by end use, 2021 - 2033 (USD Million)
  • Table 75 Asia Pacific immunoassay market, by country, 2021 - 2033 (USD Million)
  • Table 76 Asia Pacific immunoassay market, by product, 2021 - 2033 (USD Million)
  • Table 77 Asia Pacific immunoassay market, by application, 2021 - 2033 (USD Million)
  • Table 78 Asia Pacific immunoassay market, by technology, 2021 - 2033 (USD Million)
  • Table 79 Asia Pacific immunoassay market, by specimen, 2021 - 2033 (USD Million)
  • Table 80 Asia Pacific immunoassay market, by end use, 2021 - 2033 (USD Million)
  • Table 81 Japan immunoassay market, by product, 2021 - 2033 (USD Million)
  • Table 82 Japan immunoassay market, by application, 2021 - 2033 (USD Million)
  • Table 83 Japan immunoassay market, by technology, 2021 - 2033 (USD Million)
  • Table 84 Japan immunoassay market, by specimen, 2021 - 2033 (USD Million)
  • Table 85 Japan immunoassay market, by end use, 2021 - 2033 (USD Million)
  • Table 86 China immunoassay market, by product, 2021 - 2033 (USD Million)
  • Table 87 China immunoassay market, by specimen, 2021 - 2033 (USD Million)
  • Table 88 China immunoassay market, by application, 2021 - 2033 (USD Million)
  • Table 89 China immunoassay market, by technology, 2021 - 2033 (USD Million)
  • Table 90 China immunoassay market, by end use, 2021 - 2033 (USD Million)
  • Table 91 India immunoassay market, by product, 2021 - 2033 (USD Million)
  • Table 92 India immunoassay market, by application, 2021 - 2033 (USD Million)
  • Table 93 India immunoassay market, by technology, 2021 - 2033 (USD Million)
  • Table 94 India immunoassay market, by specimen, 2021 - 2033 (USD Million)
  • Table 95 India immunoassay market, by end use, 2021 - 2033 (USD Million)
  • Table 96 Australia immunoassay market, by product, 2021 - 2033 (USD Million)
  • Table 97 Australia immunoassay market, by application, 2021 - 2033 (USD Million)
  • Table 98 Australia immunoassay market, by technology, 2021 - 2033 (USD Million)
  • Table 99 Australia immunoassay market, by specimen, 2021 - 2033 (USD Million)
  • Table 100 Australia immunoassay market, by end use, 2021 - 2033 (USD Million)
  • Table 101 South Korea immunoassay market, by product, 2021 - 2033 (USD Million)
  • Table 102 South Korea immunoassay market, by application, 2021 - 2033 (USD Million)
  • Table 103 South Korea immunoassay market, by technology, 2021 - 2033 (USD Million)
  • Table 104 South Korea immunoassay market, by specimen, 2021 - 2033 (USD Million)
  • Table 105 South Korea immunoassay market, by end use, 2021 - 2033 (USD Million)
  • Table 106 Thailand immunoassay market, by product, 2021 - 2033 (USD Million)
  • Table 107 Thailand immunoassay market, by application, 2021 - 2033 (USD Million)
  • Table 108 Thailand immunoassay market, by technology, 2021 - 2033 (USD Million)
  • Table 109 Thailand immunoassay market, by specimen, 2021 - 2033 (USD Million)
  • Table 110 Thailand immunoassay market, by end use, 2021 - 2033 (USD Million)
  • Table 111 Latin America immunoassay market, by country, 2021 - 2033 (USD Million)
  • Table 112 Latin America immunoassay market, by product, 2021 - 2033 (USD Million)
  • Table 113 Latin America immunoassay market, by application, 2021 - 2033 (USD Million)
  • Table 114 Latin America immunoassay market, by technology, 2021 - 2033 (USD Million)
  • Table 115 Latin America immunoassay market, by specimen, 2021 - 2033 (USD Million)
  • Table 116 Latin America immunoassay market, by end use, 2021 - 2033 (USD Million)
  • Table 117 Brazil immunoassay market, by product, 2021 - 2033 (USD Million)
  • Table 118 Brazil immunoassay market, by application, 2021 - 2033 (USD Million)
  • Table 119 Brazil immunoassay market, by technology, 2021 - 2033 (USD Million)
  • Table 120 Brazil immunoassay market, by specimen, 2021 - 2033 (USD Million)
  • Table 121 Brazil immunoassay market, by end use, 2021 - 2033 (USD Million)
  • Table 122 Argentina immunoassay market, by product, 2021 - 2033 (USD Million)
  • Table 123 Argentina immunoassay market, by application, 2021 - 2033 (USD Million)
  • Table 124 Argentina immunoassay market, by technology, 2021 - 2033 (USD Million)
  • Table 125 Argentina immunoassay market, by specimen, 2021 - 2033 (USD Million)
  • Table 126 Argentina immunoassay market, by end use, 2021 - 2033 (USD Million)
  • Table 127 MEA immunoassay market, by country, 2021 - 2033 (USD Million)
  • Table 128 MEA immunoassay market, by product, 2021 - 2033 (USD Million)
  • Table 129 MEA immunoassay market, by application, 2021 - 2033 (USD Million)
  • Table 130 MEA immunoassay market, by technology, 2021 - 2033 (USD Million)
  • Table 131 MEA immunoassay market, by specimen, 2021 - 2033 (USD Million)
  • Table 132 MEA immunoassay market, by end use, 2021 - 2033 (USD Million)
  • Table 133 South Africa immunoassay market, by product, 2021 - 2033 (USD Million)
  • Table 134 South Africa immunoassay market, by application, 2021 - 2033 (USD Million)
  • Table 135 South Africa immunoassay market, by technology, 2021 - 2033 (USD Million)
  • Table 136 South Africa immunoassay market, by specimen, 2021 - 2033 (USD Million)
  • Table 137 South Africa immunoassay market, by end use, 2021 - 2033 (USD Million)
  • Table 138 Saudi Arabia immunoassay market, by product, 2021 - 2033 (USD Million)
  • Table 139 Saudi Arabia immunoassay market, by application, 2021 - 2033 (USD Million)
  • Table 140 Saudi Arabia immunoassay market, by technology, 2021 - 2033 (USD Million)
  • Table 141 Saudi Arabia immunoassay market, by specimen, 2021 - 2033 (USD Million)
  • Table 142 Saudi Arabia immunoassay market, by end use, 2021 - 2033 (USD Million)
  • Table 143 UAE immunoassay market, by product, 2021 - 2033 (USD Million)
  • Table 144 UAE immunoassay market, by application, 2021 - 2033 (USD Million)
  • Table 145 UAE immunoassay market, by technology, 2021 - 2033 (USD Million)
  • Table 146 UAE immunoassay market, by specimen, 2021 - 2033 (USD Million)
  • Table 147 UAE immunoassay market, by end use, 2021 - 2033 (USD Million)
  • Table 148 Kuwait immunoassay market, by product, 2021 - 2033 (USD Million)
  • Table 149 Kuwait immunoassay market, by application, 2021 - 2033 (USD Million)
  • Table 150 Kuwait immunoassay market, by technology, 2021 - 2033 (USD Million)
  • Table 151 Kuwait immunoassay market, by specimen, 2021 - 2033 (USD Million)
  • Table 152 Kuwait immunoassay market, by end use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Immunoassay market segmentation
  • Fig. 2 Data analysis models
  • Fig. 3 Market formulation and validation
  • Fig. 4 Data validating & publishing
  • Fig. 5 Market research process
  • Fig. 6 Information procurement
  • Fig. 7 Primary research
  • Fig. 8 Value-chain-based sizing & forecasting
  • Fig. 9 QFD modelling for market share assessment
  • Fig. 10 Market formulation & validation
  • Fig. 11 Commodity flow analysis
  • Fig. 12 Market outlook
  • Fig. 13 Segment snapshot-1
  • Fig. 14 Segment snapshot-2
  • Fig. 15 Competitive landscape snapshot
  • Fig. 16 Market trends & outlook
  • Fig. 17 Porter's five force analysis
  • Fig. 18 PESTEL analysis
  • Fig. 19 Immunoassay market: Product outlook key takeaways
  • Fig. 20 Immunoassay market: Product movement analysis
  • Fig. 21 Assays, kits, and reagents market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 22 ELISA Reagents & Kits market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 23 Rapid Tests Reagents & Kits market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 24 ELISPOT Reagents & Kits market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 25 Western Blot Reagents & Kits market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 26 Other Reagents & Kits market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 27 Analyzers/Instruments and systems market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 28 Software and services market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 29 Open Ended Systems market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 30 Closed Ended Systems market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 31 Immunoassay market: Application outlook key takeaways
  • Fig. 32 Immunoassay market: Application movement analysis
  • Fig. 33 Therapeutic Drug Monitoring
  • Fig. 34 Oncology market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 35 Cardiology market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 36 Endocrinology market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 37 Infectious Disease Testing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 38 Autoimmune Diseases market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 39 Others market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 40 Immunoassay market: Technology outlook key takeaways
  • Fig. 41 Immunoassay market: Technology movement analysis
  • Fig. 42 Radioimmunoassay (RIA) market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 43 Enzyme Immunoassays (EIA) market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 44 Rapid Test market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 45 Others market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 46 Chemiluminescence Immunoassays (CLIA) market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 47 Fluorescence Immunoassays (FIA) market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 48 Immunoassay market: Specimen outlook key takeaways
  • Fig. 49 Immunoassay market: Specimen movement analysis
  • Fig. 50 Blood market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 51 Saliva market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 52 Urine market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 53 Others market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 54 Immunoassay market: End use outlook key takeaways
  • Fig. 55 Immunoassay market: End use movement analysis
  • Fig. 56 Hospitals market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 57 Blood Banks market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 58 Clinical Laboratories market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 59 Pharmaceutical and Biotech Companies market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 60 Academic Research Centers market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 61 Others market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 62 Regional marketplace outlook, 2025 & 2033 (USD Million)
  • Fig. 63 Regional marketplace: Key takeaways
  • Fig. 64 North America immunoassay market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 65 Key country dynamics
  • Fig. 66 U.S. immunoassay market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 67 Key country dynamics
  • Fig. 68 Canada immunoassay market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 69 Key country dynamics
  • Fig. 70 Mexico immunoassay market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 71 Europe immunoassay market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 72 Key country dynamics
  • Fig. 73 UK immunoassay market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 74 Key country dynamics
  • Fig. 75 Germany immunoassay market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 76 Key country dynamics
  • Fig. 77 France immunoassay market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 78 Key country dynamics
  • Fig. 79 Spain immunoassay market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 80 Key country dynamics
  • Fig. 81 Italy immunoassay market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 82 Key country dynamics
  • Fig. 83 Denmark immunoassay market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 84 Key country dynamics
  • Fig. 85 Sweden immunoassay market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 86 Key country dynamics
  • Fig. 87 Norway immunoassay market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 88 Asia Pacific immunoassay market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 89 Key country dynamics
  • Fig. 90 Japan immunoassay market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 91 Key country dynamics
  • Fig. 92 China immunoassay market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 93 Key country dynamics
  • Fig. 94 India immunoassay market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 95 Key country dynamics
  • Fig. 96 Australia immunoassay market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 97 Key country dynamics
  • Fig. 98 South Korea immunoassay market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 99 Key country dynamics
  • Fig. 100 Thailand immunoassay market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 101 Key country dynamics
  • Fig. 102 Market participant categorization
  • Fig. 103 Immunoassay market position analysis, 2023
  • Fig. 104 Strategic framework